Alendronate Sodium Tablets 10?mg – Low price wholesale comparison

描述

Alendronate Sodium is a potent nitrogen-containing bisphosphonate that inhibits farnesyl pyrophosphate synthase in osteoclasts, reducing bone resorption and increasing bone density. Widely used for research in osteoporosis modeling, Paget’s disease, and bone metabolism dynamics. The Kaijian formulation provides a consistent 10?mg dose per tablet, enabling controlled in vitro and in vivo studies on skeletal tissues.

Manufactured by Hainan Kaijian Pharmaceutical Co., Ltd., this product is approved under China’s NMPA registration number H20064818, drug code 86905788000016, barcode 6935642308068. Ideal for preclinical research settings. ?? Not intended for therapeutic use.

Alendronate Sodium Tablets Product Specifications

Alendronate Sodium Tablets Mechanism & Research Applications

Alendronate Sodium works by binding to bone hydroxyapatite and inhibiting osteoclast-mediated bone resorption via farnesyl pyrophosphate synthase inhibition. It’s widely used for:

• Osteoporosis and bone density modeling

• Investigating Paget’s disease in preclinical studies

• Bone turnover and remodeling assays

• Muscle–bone interaction models

• Comparative studies with other bisphosphonates

Alendronate Sodium Tablets Side Effects (Research Observations)

Research and clinical data report potential effects such as:

• Gastric and esophageal irritation or ulceration

• Reduced calcium absorption and transient hypocalcemia

• Musculoskeletal discomfort or bone/joint pain

• Rare adverse effects in long-term dosing: osteonecrosis of the jaw, atypical femur fractures

Use proper monitoring and welfare protocols in in vivo models.

Safety & Handling

• Use Restriction: Laboratory research only; not for clinical, therapeutic, or veterinary use

• Handling: Use lab-grade PPE—gloves, lab coat, and eye protection

• Storage: Keep sealed at 20–25?°C, away from moisture

• Disposal: Dispose unused tablets following institutional hazardous waste guidelines

Core Keywords

Alendronate sodium tablets, Kaijian alendronate, 10?mg bisphosphonate research, bone resorption inhibitor, osteoporosis model compound, lab-grade alendronate, NMPA H20064818 alendronate, Hainan Kaijian alendronate, wholesale bone research tablets

Research Use Disclaimer

This product is exclusively for laboratory research use and not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may pose safety or regulatory risks. Always use within authorized institutional biosafety protocols.